S I Lee - Sungkyunkwan University, Sungkyunkwan University

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 9 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract 5990: Microtubule-associated serine/threonine kinase-likeinhibitor, AD1208, as a novel cancer therapeutics

SOONGYU CHOI, JS Ahn, KS Baek,YL Choi, MY Im, JH Kim, JW Kim, JH Khoo,SH Lee, WL Yao, Young-Whan Park

Cancer Researchno. 6_Supplement (2024): 5990-5990

引用0浏览0引用

11P Patritumab deruxtecan (HER3-DXd) in previously treated patients (pts) with advanced EGFR-mutated (EGFRm) NSCLC: Updated safety results from HERTHENA-Lung01

H. Hayashi, Y. Goto, H.A. Yu, P.A. Jänne,J.C-H. Yang, M. Reck, K. Yoh,S-H. Lee, L. Paz-Ares, B. Besse, P. Bironzo,D-W. Kim,

ESMO Open (2024)

引用0浏览0引用

104TiP Phase Ib/IIa study of ATR inhibitor tuvusertib + anti-PD-1 cemiplimab in patients with advanced non-squamous (nsq) non-small cell lung cancer (NSCLC) that has progressed on prior anti-PD-(L)1 and platinum-based therapies

L. Paz-Ares, F. Cappuzzo, N. Yamamoto, N. Vokes, J.E. Gray, T.K. Owonikoko, R. Ariyasu, H. Ishii, J.H. Kang,S-H. Lee, R. Hallwachs, A. Coenen-Stass,

ESMO Open (2024)

引用0浏览0引用

1319MO Intracranial efficacy of HER3-DXd in patients with previously treated advanced EGFR-mutated NSCLC: Results from HERTHENA-Lung01

M.L. Johnson, P.A. Jänne, Y. Goto, K. Yoh,S-H. Lee, L. Paz-Ares, B. Besse,S. Novello, H. Hayashi,D-W. Kim,T. John, S.C-H. Kao,

Annals of Oncology (2023): S760-S761

引用0浏览0引用

655O Phase Ib study of cofetuzumab pelidotin, an anti-PTK7 antibody-drug conjugate, in patients with PTK7-expressing recurrent non-small cell lung cancer (rNSCLC)

B.C. Cho,M.L. Johnson, J. Bar, E. Schaefer, K. Yoh, A. Zer, M.T. Moskovitz,S-H. Lee,V. Moreno Garcia,M.J. De Miguel Luken, Y. Okuma, J-H. Kim,

Annals of Oncology（2023）

引用0浏览0引用

Skyscraper-09: A Phase Ii, Randomised, Double-Blinded Study Of Atezolizumab (Atezo) Plus Tiragolumab (Tira) And Atezo Plus Placebo As First-Line (1l) Therapy For Recurrent/Metastatic (R/M) Pd-L1+Squamous Cell Carcinoma Of The Head And Neck (Scchn)

E. Cohen, J. Fayette,K. J. Harrington,M. L. Johnson,H-F. Kao,S-H. Lee, L. F. Licitra,N. Ngamphaiboon,A. Psyrri, D. J. Wong, M. Afshari, K. Cvijovic,

ANNALS OF ONCOLOGY（2021）

引用2浏览0引用

927TiP SKYSCRAPER-09: A phase II, randomised, double-blinded study of atezolizumab (Atezo) + tiragolumab (Tira) and atezo + placebo as first-line (1L) therapy for recurrent/metastatic (R/M) PD-L1+ squamous cell carcinoma of the head and neck (SCCHN)

E. Cohen, J. Fayette, K.J. Harrington, M.L. Johnson,H-F. Kao,S-H. Lee, L.F. Licitra, N. Ngamphaiboon, A. Psyrri, D.J. Wong, M. Afshari, K. Cvijovic,

Annals of Oncology (2021): S814-S815

引用0浏览0引用

Nasal-type NK|[sol]|T cell lymphoma: clinical features and treatment outcome

J Lee,W S Kim,Y H Park,S H Park,K W Park, J H Kang,S S Lee,S I Lee,S-H Lee, K Kim,C W Jung,Y C Ahn,

British Journal of Cancerno. 7 (2005): 1226-1230

引用74浏览0WOSNATURE引用

Investigation Of Inclusion Complexation Of Paclitaxel By Cyclosophoraoses And Cyclodextrins

Sh Jung,Sh Lee,Dh Seo,Yj Choi

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY（2001）

引用0浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn